In addition, pharmacological inhibition or genetic ablation of sEH abolishes obesity-induced colonic inflammation (cytokine expression and immune cell infiltration into the colon) and the activation of pro-tumorigenic Wnt signaling (phosphorylation of GSK3β and expression of Axin2 in the colon) [41]. Here, EPHX2 is linked to obesity disorder.